Newsletter No. 107 -- October 2008
CLARIFICATION OF THE SCOPE AND REQUIREMENTS OF PAR-08-225, "QUANTITATIVE IMAGING FOR EVALUATION OF RESPONSES TO CANCER THERAPIES (U01)" (NCI) (NOT-CA-08-028)
SBIR PHASE II BRIDGE AWARDS TO ACCELERATE THE DEVELOPMENT OF NEW CANCER THERAPIES AND CANCER IMAGING TECHNOLOGIES TOWARD COMMERCIALIZATION (SBIR [R44]) (NCI)(CA-08-021)
Letter of intent receipt date: January 27, 2009
Application date: February 27, 2009
This Funding Opportunity Announcement (FOA), launched as a pilot initiative at the National Institutes of Health (NIH) by the National Cancer Institute (NCI), solicits Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) that seek additional NIH funding to support the next stage of development for previously-funded NIH SBIR Phase II projects applicable to cancer therapies and cancer imaging technologies. This FOA is only open to current and recently expired NIH SBIR Phase II projects. Current NIH SBIR Phase II awardees must be in the final year of their Phase II project period to apply. In general, past Phase II projects should have ended within 24 months of the application receipt date.
NIH Offers New Dual-Track Commercialization Assistance Program to SBIR Phase II Awardees (NOT-OD-08-113)
AIRWAY SMOOTH MUSCLE FUNCTION AND TARGETED THERAPEUTICS IN HUMAN ASTHMA (R01)(NHLBI) (RFA-HL-09-007) Letter of intent receipt date: December 8, 2008
Application receipt date: January 06, 2009
The purpose of this funding opportunity announcement (FOA), issued by the NHLBI, NIH, is to solicit Research Project Grant (R01) applications from institutions/organizations that propose to investigate the complex role of airway smooth muscle (ASM) functions in the development of human asthma and identify novel therapeutic targets. Examples of research objectives include developing novel imaging approaches to characterize ASM contraction in vivo in humans and biomarkers that reflect ASM phenotype and function;
EXPLORATORY CENTERS FOR TRANSLATIONAL RESEARCH ON THE CLINICAL NEUROBIOLOGY OF DRUG ADDICTION (P20) (NIDA) (RFA-DA-09-012)
Letter of intent receipt date: January 27, 2009
Application receipt date: February 27, 2009
This solicitation invites applications for the development of Exploratory Translational Research Centers on the clinical neurobiology of drug abuse and addiction. For purposes of this FOA, an Exploratory Translational Research Center is defined as an entity with a strong primary human neurobiology focus in which preclinical research is included to directly inform or provide a mechanistic foundation for the human neuroscience/neurobiological research.
TRANSLATING BASIC BEHAVIORAL AND SOCIAL SCIENCE DISCOVERIES INTO INTERVENTIONS TO REDUCE OBESITY: CENTERS FOR BEHAVIORAL INTERVENTION DEVELOPMENT (U01) (NHLBI, NCI, NIDDK, OBSSR) (RFA-HL-08-013)
Letter of intent receipt date: December 16, 2008
Application receipt date: January 13, 2009
This FOA solicits cooperative agreement (U01) applications from institutions/organizations that propose to translate findings from basic research on human behavior into more effective clinical, community, and population interventions to reduce obesity and improve obesity-related behaviors. Among suggestions of research topics is the following: neuroscience researchers, using data from imaging techniques that map the brain regions and neural processes underlying addictive and appetitive behaviors, could collaborate with cognitive and social psychologists studying impulsivity, emotional dysregulation and risk-taking behavior, to better design interventions that prevent cravings, promote delayed gratification, and improve individuals' abilities to cope with relapse-eliciting stimuli, such as food ads or presence of unhealthy foods in the social environment.
COMPARATIVE INTERDISCIPLINARY STUDIES OF CEREBRAL CORTICAL DEVELOPMENT (R21/R33) (NIMH) (RFA-MH-09-080)
Letter of intent receipt date: October 28, 2008
Application receipt date: November 28, 2008
This Funding Opportunity Announcement (FOA), issued by the National Institute on Mental Health (NIMH), solicits Exploratory/Developmental Phased Innovation (R21/R33) grant applications from institutions/organizations that propose to study the development of the cerebral cortex and associated structures in humans or other mammalian model systems across three axes: time, species, and discipline. The use of multiple research approaches, including functional imaging, lesion, stimulation, neurophysiological, pharmacological, anatomical, molecular, and genetic approaches is strongly encouraged.
RESEARCH ON EMERGENCY MEDICAL SERVICES FOR CHILDREN (R01) (MULTIPLE INSTITUTES) (PAR-08-261)
Letters of intent receipt dates: December 15, 2008, August 19, 2009, August 15, 2010
Application receipt/submission date(s): January 15, 2009, September 19, 2009, September 15, 2010
This multi-agency program Funding Opportunity Announcement (FOA) is designed to improve the quality and quantity of research related to emergency medical services for children (EMSC), with the goal of reducing morbidity and mortality in children through improved care delivery. Topics for research include interventions that include technology in biomedical imaging and bioengineering that reduce need for emergency medical care services for children.
MEDICATIONS DEVELOPMENT CENTERS OF EXCELLENCE (P50) (NIDA) (RFA-DA-09-002)
Letters of Intent Receipt Date: November 19, 2008
Application Receipt Date: December 19, 2008
The purpose of this FOA is to solicit Center Grant (P50) applications to provide support for research centers (Medications Development Centers of Excellence (MDCEs)) dedicated to clinical research directed towards the identification, evaluation and development of safe and effective medications for treatment of substance related disorders (SRDs), alone or with comorbid conditions. Examples of research components include investigating innovative imaging technologies to assess subjects' suitability for specific treatments, as well as treatment progress and outcome (imaging studies must be focused on treatment).
INTELLECTUAL AND DEVELOPMENTAL DISABILITIES RESEARCH CENTERS 2009 (P30) (NICHD) (RFA-HD-08-016)
Letters of Intent Receipt Date: November 21, 2008
Application Receipt Date: December 22, 2008
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) invites applications for Center Core Grants designed to advance the diagnosis, prevention, treatment, and amelioration of intellectual and developmental disabilities (IDD). Examples of topics include studies that develop and test novel methods and measures for screening and diagnosis, and/or identify children and infants at risk; validation of emerging technologies (e.g., microarrays, proteomics, microanalysis of analyates, biomolecule sensing, mass spectrometry, functional imaging) for screening and diagnosis and studies to follow the developmental trajectories of different brain functions and their influence on developing cognitive and motor skills; such studies might use techniques of imaging, electrophysiology, pharmacology, molecular biology, and behavioral science.
SUMMER INSTITUTE FOR TRAINING IN BIOSTATISTICS II (T15) (NHLBI, NCRR) (RFA-HL-09-009)
Letters of Intent Receipt Date: December 5, 2008
Application Receipt Date: January 6, 2009
The National Heart, Lung and Blood Institute (NHLBI) and the National Center for Research Resources (NCRR) invite applications for training grants to develop, conduct, and evaluate summer courses in the basic principles and methods of biostatistics as employed in biomedical research.
CIP DCIDE PROGRAM
The Cancer Imaging Program of the NCI requests submissions for its Development of Clinical Imaging Drugs and Enhancers (DCIDE) initiative. The goal is the rapid movement of promising, novel cancer imaging enhancers or molecular probes from the laboratory to proof of principle clinical trials. See the web site for details.
GUEST AUTHOR OPPORTUNITIES IN THE NIH MICAD DATABASE
The Molecular Imaging and Contrast Agent Database (MICAD) program has been developed as a key component of the NIH Molecular Imaging Roadmap to provide freely accessible online scientific information on in vivo molecular imaging and contrast agents. To accelerate expansion of the database to include all published agents, the MICAD program has implemented a procedure for members of the imaging community to write and submit entries (chapters) as guest authors to the database. All members of the imaging community are encouraged to consider this guest author opportunities. For further information, please contact the MICAD staff at email@example.com. Individual guest authors will be provide with detailed instructions, style guidelines, and a chapter template. The name of the contributing author(s) will be acknowledged and included in the MICAD online publication.
FDA Proposes Breast Cancer Thermal Ablation Registry and Requests Comments
The FDA has proposed a new registry and requests comments on whether it "could facilitate standardization of feasibility trials studying local treatment of small breast cancers" with technologies such as cryoablation, focused ultrasound, interstitial lasers, microwave ablation and radiofrequency ablation. FDA also suggests that a registry could lead to breast cancer ablation best-practices and pave the way for larger prospective clinical trials. Those interested to provide comments should visit http://www.regulations.gov, enter docket FDA-2008-N-0280, click on "Notices" under Document Type in the left menu, click on "Send a Comment or Submission" to enter your comments. The docket for public comments closes on 11/24/08.
Extension of Expiration Date for PA-06-012 (STTR) and PA-06-013 (SBIR) -- Manufacturing Processes of Medical, Dental, and Biological Technologies (NOT-OD-08-116)
Announcing Initial Implementation Timeline for Enhancing Peer Review (NOT-OD-08-118)
In June 2007, NIH initiated an effort to formally review the NIH peer review system. External and internal working groups deliberated on challenges and recommendations regarding enhancements to the review system. The recommendations that are being implemented are based on the results of the diagnostic phase and significant dialogue with both the internal and external communities. The preliminary implementation plans for the 2009 through 2010 calendar years are outlined.
Clarification of NIH Policy on Late Submission of Grant Applications (NOT-OD-08-111)
The change relates to service by the PI on an NIH extramural review group or other NIH panel or board.
Non-Competing Grant Awards under the Current Continuing Resolution (NOT-OD-09-002)
The Department of Health and Human Services (HHS) continues to operate on a continuing resolution (CR) [Public Law 110-329 Consolidated Security, …, 2009] that currently extends through March 6, 2009. The CR applies the terms of the FY 2008 appropriations for the period covered by the CR. Until the final FY 2009 appropriation is enacted, NIH will issue non-competing research grant awards at a level below that indicated on the most recent Notice of Award (generally up to 90% of the previously committed level).
Announcing Transition Schedule for NIH/AHRQ/CDC/NIOSH/FDA to Adobe-based Forms for SF424 Research and Related (R&R) Electronic Submissions through Grants.gov (NOT-OD-08-117)
This Notice provides the Transition Schedule for NIH/AHRQ/CDC/NIOSH/FDA from PureEdge to Adobe-based grant application forms for electronic submissions of SF424 Research and Related (R&R) applications. Most electronic submissions to NIH on or after January 1, 2009, must use Adobe application forms.
Encouraging Early Transition to Research Independence: Modifying the NIH New Investigator Policy to Identify Early Stage Investigators (NOT-OD-08-121)
This notice describes a change in NIH New Investigator policies designed to encourage early transition to independence. New Investigators within ten years of completing their terminal research degree or within ten years of completing their medical residency will be designated Early Stage Investigators (ESIs). Traditional NIH research grant (R01s) applications from ESIs will be identified and the career stage of the applicant will be considered at the time of review and award.
Reminder Concerning Grantee Compliance with Public Access Policy and Related NIH Monitoring Activities (NOT-OD-08-119)
Seventh International Conference on the Ultrasonic Measurement and Imaging of Tissue Elasticity
October 27-30, 2008, The Lakeway Resort and Spa, Lake Travis, Austin, TX
2nd Annual Small Animal and Molecular Imaging Workshop
October 30-31, 2008, Jordan Hall Conference Center, University of Virginia, Charlottesville, VA
4th Annual Small Animal Imaging Workshop
November 5-8, 2008, Clark Auditorium, Stanford University
5th Annual Memphis BioImaging Conference November 6-7, 2008, Fogelman Executive Conference Center, Memphis, TN
2008 RSNA Meeting, CIP in Booth 2518
November 30 - December 5, 2008, McCormick Place, Chicago, Illinois
BIROW 6 Workshop
January 15-16, 2009, Bethesda North Convention Center, Bethesda, MD
SPIE Medical Imaging 2009
February 7-12, 2009, Disney Coronado Springs Resort, Lake Buena Vista (Orlando Area), Florida
4th Annual Symposium on PET/CT and Molecular Imaging
February 12-14, 2009, Bellagio Hotel, Las Vegas, NV
If you wish to remain on the list, no action is necessary. If you wish to be added to the list, please contact Dr Barbara Croft by return e-mail (firstname.lastname@example.org). Please include your complete mailing address, title, phone and fax numbers.
Cancer Imaging Program,
Division of Cancer Treatment and Diagnosis,
NCI 6130 Executive Boulevard - MSC-7412
Bethesda, MD 20892-7412
Tel: 301 496 9531
Fax: 301 480 3507